Skip to content
FIND A BIOALPS ACTOR
Sensawear

A wearable tissue health monitor

31.08.2022
Share this article

Sensawear wins a CHF 150,000 Venture Kick grant to develop its wearable tissue health monitor

 

Sensawear has developed the world’s first truly wearable, textile-based, tissue oxygenation monitoring sensor using trusted, proven, non-invasive near-infrared spectroscopy. Specially integrated fiber optics will give users real-time feedback on deep tissue oxygen saturation without adding pressure against the skin. These sensors are single-use disposables that can be continuously worn between 24 and 72 hours. Being breathable, waterproof, and gentle on the skin, these sensors can be worn without irritating the skin with friction or moisture.

This technology will help prevent painful and dangerous pressure injuries and/or pressure ulcers from forming, as well as provide continuous monitoring in post-op and traumatology wards to improve surgical recovery and replace invasive monitoring procedures, thus improving quality of life and quality of care for millions of people around the world.

Sensawear will use the CHF 150,000 Venture Kick funding to work with industrial partners to further advance and market the sensors to hospitals and clinics, addressing an estimated USD 850 million market potential across multiple applications.

Prof. Dr. Ursula Wolf is a co-founder, the CMO, and the Chairwoman of the Board of Sensawear. She brings expertise in near-infrared technology and decades of clinical and medical research experience. Dr. Oliver Kress is a co-founder and the CEO of the startup. He has a background in physics and a strong desire to commercialize revolutionary technology in the med-tech field. Co-founder Tarcisi Cantieni is the CTO and will direct Sensawear’s research and development. All three co-founders are based at the University of Bern’s Institute for Complementary and Integrative Medicine (IKIM).

 

Source: Press Release